Grimes & Company, Inc. I Specimen Inc. Transaction History

Grimes & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$0.46 - $0.66 $11,670 - $16,744	-25,371 Reduced 45.15%	30,818 $15,000
Q3 2023 Oct 19, 2023	SELL	$0.61 - $1.69 $5,734 - $15,886	-9,400 Reduced 14.33%	56,189 $34,000
Q4 2022 Jan 25, 2023	SELL	$1.19 - $1.74 $2 - $3	-2 Reduced -0.0%	65,589 $0
Q3 2022 Oct 28, 2022	BUY	$1.51 - $2.96 $5,401 - $10,587	3,577 Added 5.77%	65,591 $108,000
Q2 2022 Jul 22, 2022	BUY	$2.18 - $4.86 $59,389 - $132,400	27,243 Added 78.35%	62,014 $135,000
Q1 2022 May 06, 2022	BUY	$3.6 - $8.5 $125,175 - $295,553	34,771 New	34,771 $187,000

56.5K

Ticker ISPC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 8,880,600
Market Cap $29.5M
Description
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, bioban...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.